PD-1 and PDL-1 Inhibitors Market Size, Share, Growth and Industry Analysis, By Types (Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab), By Applications (Stomach Cancer, Liver Cancer, Kidney Ccancer, Bladder Cancer, Cervical Cancer, Other), Regional Insights and Forecast to 2035

Last Updated: 09-February-2026
Base Year: 2025
Historical Data: 2021-2024

Region: Global
Format: PDF
Report ID: GGI116569
SKU ID: 29562118
Pages: 88

Download FREE Sample

Buy Now

1000+

GLOBAL LEADERS TRUST US

Chapter 1 – Introduction

1.1 Research Objectives

1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency Considered

Chapter 2 – Research Methodology

2.1 Research Approaches
2.1.1 Top-down Approach
2.1.2 Bottom-up Approach
2.1.3 Data Validation
2.2 List of Primary Sources

2.3 List of Secondary Sources

Chapter 3 – Executive Summary

3.1 Market Snapshot
3.2 Segment Snapshot
3.3 Competitive Landscape Snapshot

Chapter 4 – Market Dynamics

4.1 Market Drivers

4.2 Market Restraints
4.3 Market Opportunities

Chapter 5 – PD-1 and PDL-1 Inhibitors Market: Key Insights

5.1 Porter’s Five Forces Analysis
5.2 PESTEL Analysis
5.3 Value Chain Analysis

5.4 Price Trend Analysis
5.5 Technological Developments

5.6 Recent Industry Developments

Chapter 6 – PD-1 and PDL-1 Inhibitors Market: Global Outlook

6.1 Key Findings

6.2 Global

6.2.1 Global PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
6.2.2 Global PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Region
6.2.2.1 North America

6.2.2.2 Europe

6.2.2.3 Asia Pacific

6.2.2.4 Latin America

6.2.2.4 Middle East & Africa

Chapter 7 – PD-1 and PDL-1 Inhibitors Market: Regional Outlook

7.1 Key Findings

7.2 North America

7.2.1 Key Market Drivers and Restraints

7.2.2 North America PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
7.2.3 North America PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Country
7.2.3.1 USA

7.2.3.2 Canada

7.2.4 USA PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.2.5 Canada PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3 Europe

7.3.1 Key Market Drivers and Restraints

7.3.2 Europe PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
7.3.3 Europe PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Country
7.3.3.1 UK

7.3.3.2 Germany

7.3.3.3 France

7.3.3.1 Italy

7.3.3.2 Spain

7.3.3.3 Rest of Europe

7.3.4 UK PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3.5 Germany PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3.6 France PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3.7 Italy PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3.8 Spain PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.3.9 Rest of Europe PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4 Asia Pacific

7.4.1 Key Market Drivers and Restraints

7.4.2 Asia Pacific PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
7.4.3 Asia Pacific PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Country
7.4.3.1 Japan

7.4.3.2 China

7.4.3.3 India

7.4.3.1 South Korea

7.4.3.2 Australia

7.4.3.3 Rest of APAC

7.4.4 Brazil PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4.5 Mexico PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4.6 Rest of LATAM PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4.7 Brazil PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4.8 Mexico PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.4.9 Rest of LATAM PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.5 Latin America

7.5.1 Key Market Drivers and Restraints

7.5.2 Middle East & Africa PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
7.5.3 Middle East & Africa PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Country
7.5.3.1 Brazil

7.5.3.2 Mexico

7.5.3.3 Rest of LATAM

7.5.4 Brazil PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.5.5 Mexico PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.5.6 Rest of LATAM PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.6 Middle East & Africa

7.6.1 Key Market Drivers and Restraints

7.6.2 Middle East & Africa PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By All Segments
7.6.3 Middle East & Africa PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By Country
7.6.3.1 UAE

7.6.3.2 South Africa

7.6.3.3 Rest of MEA

7.6.4 UAE PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.6.5 South Africa PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

7.6.6 Rest of MEA PD-1 and PDL-1 Inhibitors Market Analysis, Insights & Forecast, 2021-2035 – By One Segment

Chapter 8 – Competitive Landscape

8.1 Comparison on Top 5 Competitors (Heat Map Analysis) – Based on Factors such as Geographic Presence, Product Mix, Growth Strategies, Etc.
8.2 Global PD-1 and PDL-1 Inhibitors Market Share / Market Ranking Analysis, 2024
8.3 Growth Strategies Adopted by Key Players

Chapter 9 – Company Profiles

9.1 For Top 10 Players in the PD-1 and PDL-1 Inhibitors Market
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financials (Based on availability)
9.1.4 Recent Developments
9.1.5 Growth Strategies

Chapter 10 – Appendix

10.1 Macroeconomic Analysis
10.2 Customization Options
10.3 About Us
10.4 Related Reports